Search This Blog

Wednesday, June 29, 2022

Lexicon: Positive Top-Line Results From Phase 2 Proof-Of-Concept Study In Diabetic Neuropathy

 Study Supports Translation of Potential New Mechanism of Action for Neuropathic Pain and Advancement of LX9211 Development in Painful Diabetic Neuropathy

Conference Call and Webcast at 8:00 a.m. Eastern Time June 30, 2022

Lexicon management will hold a live conference call and webcast on June 30, 2022 at 8:00 am ET / 7:00 am CT to discuss the RELIEF-DPN-1 top-line results. The dial-in number for the conference call is 888-886-7786 (U.S./Canada) or 416-764-8658 (international). The conference ID for all callers is 20954316. The live webcast and replay may be accessed by visiting Lexicon’s website at www.lexpharma.com/events. An archived version of the webcast will be available on the website for 14 days.

https://finance.yahoo.com/news/lexicon-announces-positive-top-line-200100262.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.